Australia markets closed

Calithera Biosciences, Inc. (CALA)

OTC Markets EXMKT - OTC Markets EXMKT Delayed price. Currency in USD
Add to watchlist
0.02000.0000 (0.00%)
As of 01:05PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
9,750
0
0
Operating expenses
Research development
37,511
28,533
53,455
71,015
76,290
Selling general and administrative
15,551
13,541
20,853
20,372
16,605
Total operating expenses
53,062
42,074
74,308
91,387
92,895
Operating income or loss
-53,062
-42,074
-64,558
-91,387
-92,895
Total other income/expenses net
1,947
1,947
-50,875
-
-
Income before tax
-101,924
-39,650
-115,088
-90,137
-89,860
Income from continuing operations
-101,924
-39,650
-115,088
-90,137
-89,860
Net income
-101,924
-39,650
-115,088
-90,137
-89,860
Net income available to common shareholders
-83,564
-21,290
-115,088
-90,137
-89,860
Basic EPS
-4.60
-
-31.16
-26.20
-38.00
Diluted EPS
-7.94
-
-31.16
-26.20
-38.00
Basic average shares
4,633
-
3,693
3,441
2,366
Diluted average shares
4,992
-
3,693
3,441
2,366